These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35198288)

  • 1. Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 Vaccines.
    Dutta S; Kaur R; Charan J; Bhardwaj P; Ambwani SR; Babu S; Goyal JP; Haque M
    Cureus; 2022 Jan; 14(1):e21376. PubMed ID: 35198288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom.
    Otero-Losada M; Petrovsky N; Alami A; Crispo JA; Mattison D; Capani F; Goetz C; Krewski D; Perez-Lloret S
    Expert Opin Drug Saf; 2023 Apr; 22(4):343-349. PubMed ID: 36043937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database.
    Jeet Kaur R; Dutta S; Charan J; Bhardwaj P; Tandon A; Yadav D; Islam S; Haque M
    Int J Gen Med; 2021; 14():3909-3927. PubMed ID: 34349544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Events Following COVID-19 Vaccination in Adolescents: Insights From Pharmacovigilance Study of VigiBase.
    Kim DH; Kim JH; Oh IS; Choe YJ; Choe SA; Shin JY
    J Korean Med Sci; 2024 Mar; 39(8):e76. PubMed ID: 38442719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of self-reported adverse events related to COVID-19 vaccines in Saudi Arabia: A nationwide study.
    Alkhalifah JM; Al Seraihi A; Al-Tawfiq JA; Alshehri BF; Alhaluli AH; Alsulais NM; Alessa MM; Seddiq W; Aljeri T; Qahtani MH; Barry M; Al-Otaiby M
    Front Public Health; 2023; 11():1043696. PubMed ID: 36908451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Adverse Events between mRNA and Adenovirus-Vectored COVID-19 Vaccines in Healthcare Workers.
    Wi YM; Kim SH; Peck KR
    Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Events Following BNT162b2 mRNA COVID-19 Vaccine Immunization among Healthcare Workers in a Tertiary Hospital in Johor, Malaysia.
    Tan AY; Chang CT; Yu YK; Low YX; Razali NFM; Tey SY; Lee SWH
    Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of COVID-19 and Vaccine on the Human Nervous System.
    Chen F; Cao P; Liu H; Cai D
    Neuroendocrinology; 2022; 112(11):1046-1057. PubMed ID: 35316815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature.
    Eslait-Olaciregui S; Llinás-Caballero K; Patiño-Manjarrés D; Urbina-Ariza T; Cediel-Becerra JF; Domínguez-Domínguez CA
    Ther Adv Drug Saf; 2023; 14():20420986231165674. PubMed ID: 37223456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults.
    Tompkins LK; Baggs J; Myers TR; Gee JM; Marquez PL; Kennedy SB; Peake D; Dua D; Hause AM; Strid P; Abara W; Rossetti R; Shimabukuro TT; Shay DK
    Vaccine; 2022 Dec; 40(52):7653-7659. PubMed ID: 36372665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative safety of mRNA COVID-19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database.
    Kim MS; Jung SY; Ahn JG; Park SJ; Shoenfeld Y; Kronbichler A; Koyanagi A; Dragioti E; Tizaoui K; Hong SH; Jacob L; Salem JE; Yon DK; Lee SW; Ogino S; Kim H; Kim JH; Excler JL; Marks F; Clemens JD; Eisenhut M; Barnett Y; Butler L; Ilie CP; Shin EC; Il Shin J; Smith L
    J Med Virol; 2022 Mar; 94(3):1085-1095. PubMed ID: 34709664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transverse Myelitis Following SARS-CoV-2 Vaccination: A Pharmacoepidemiological Study in the World Health Organization's Database.
    Nguyen S; Bastien E; Chretien B; Sassier M; Defer G; Nehme A; Lelong-Boulouard V; Alexandre J; Fedrizzi S; Morice PM
    Ann Neurol; 2022 Dec; 92(6):1080-1089. PubMed ID: 36054163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Guillain-Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database.
    Kim JE; Park J; Min YG; Hong YH; Song TJ
    J Peripher Nerv Syst; 2022 Sep; 27(3):206-214. PubMed ID: 35751472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events following COVID-19 vaccination in South Korea between February 28 and August 21, 2021: A nationwide observational study.
    Lee DS; Kim JW; Lee KL; Jung YJ; Kang HW
    Int J Infect Dis; 2022 May; 118():173-182. PubMed ID: 35276381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global burden of vaccine-associated rheumatic diseases and their related vaccines, 1967-2023: A comprehensive analysis of the international pharmacovigilance database.
    Oh J; Jo H; Park J; Lee H; Kim HJ; Lee H; Kang J; Hwang J; Woo S; Son Y; Kim S; Smith L; Rahmati M; Jacob L; Lee J; Lee JH; López Sánchez GF; Dragioti E; Udeh R; Veronese N; Soysal P; Woo HG; Yon DK
    Int J Rheum Dis; 2024 Aug; 27(8):e15294. PubMed ID: 39171515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of neuralgic amyotrophy with COVID-19 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database.
    Kim JE; Park J; Min YG; Hong YH; Song TJ
    Muscle Nerve; 2022 Dec; 66(6):766-770. PubMed ID: 36214181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral adverse events following COVID-19 and influenza vaccination in Australia.
    Riad A; Issa J; Attia S; Dušek L; Klugar M
    Hum Vaccin Immunother; 2023 Aug; 19(2):2253589. PubMed ID: 37734344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The descriptive epidemiology of adverse events following two doses of mRNA COVID-19 vaccination in Curaçao, the Caribbean.
    Lambo J; Keli S; Kaplan SK; Njideaka-Kevin T; Arja SB; Khedir Omer Altahir A; Olonade I; Kumar R
    Infect Dis (Lond); 2024 Sep; ():1-13. PubMed ID: 39226235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS.
    Yan MM; Zhao H; Li ZR; Chow JW; Zhang Q; Qi YP; Wu SS; Zhong MK; Qiu XY
    Front Pharmacol; 2022; 13():921760. PubMed ID: 36419624
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcomes of single dose COVID-19 vaccines: Eight month follow-up of a large cohort in Saudi Arabia.
    Alharbi NK; Al-Tawfiq JA; Alghnam S; Alwehaibe A; Alasmari A; Alsagaby SA; Alsubaie F; Alshomrani M; Farahat FM; Bosaeed M; Alharbi A; Aldibasi O; Assiri AM
    J Infect Public Health; 2022 May; 15(5):573-577. PubMed ID: 35472755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.